These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23117021)

  • 1. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies.
    Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
    Int J Pharm; 2013 Jan; 441(1-2):636-42. PubMed ID: 23117021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment.
    Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
    J Pharm Sci; 2014 Nov; 103(11):3448-3456. PubMed ID: 25219511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
    Mohaghegh M; Tafaghodi M
    Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure function attributes of gold nanoparticle vaccine association: effect of particle size and association temperature.
    Barhate GA; Gaikwad SM; Jadhav SS; Pokharkar VB
    Int J Pharm; 2014 Aug; 471(1-2):439-48. PubMed ID: 24907644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vivo study of dry powder microspheres for nasal immunization.
    Tafaghodi M; Rastegar S
    J Drug Target; 2010 Apr; 18(3):235-42. PubMed ID: 19929307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
    Pirouzmand H; Khameneh B; Tafaghodi M
    Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
    Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines.
    Klein K; Mann JF; Rogers P; Shattock RJ
    J Control Release; 2014 Jun; 183():43-50. PubMed ID: 24657807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.
    Wang T; Jiang H; Zhao Q; Wang S; Zou M; Cheng G
    Int J Pharm; 2012 Oct; 436(1-2):351-8. PubMed ID: 22721849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles.
    Sudheesh MS; Vyas SP; Kohli DV
    Drug Deliv; 2011 Jul; 18(5):320-30. PubMed ID: 21351824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan microparticles as oral delivery system for tetanus toxoid.
    Ahire VJ; Sawant KK; Doshi JB; Ravetkar SD
    Drug Dev Ind Pharm; 2007 Oct; 33(10):1112-24. PubMed ID: 17852363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
    Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ
    Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.
    Westerink MA; Smithson SL; Srivastava N; Blonder J; Coeshott C; Rosenthal GJ
    Vaccine; 2001 Dec; 20(5-6):711-23. PubMed ID: 11738734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
    Sarti F; Perera G; Hintzen F; Kotti K; Karageorgiou V; Kammona O; Kiparissides C; Bernkop-Schnürch A
    Biomaterials; 2011 Jun; 32(16):4052-7. PubMed ID: 21377204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Jaafari MR; Sajadi Tabassi SA
    Eur J Pharm Biopharm; 2006 Oct; 64(2):138-45. PubMed ID: 16797952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity.
    Mann JF; Scales HE; Shakir E; Alexander J; Carter KC; Mullen AB; Ferro VA
    Methods; 2006 Feb; 38(2):90-5. PubMed ID: 16414269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.